Royalty Pharma Ratios (2019-2025) | RPRX

Ratios Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 91.08%94.78%316.19%21.78%117.82%115.95%64.08%27.74%145.37%37.86%9.32%22.79%91.72%38.44%-107.83%74.43%65.28%22.76%120.39%-0.75%36.18%142.80%56.32%76.28%15.66%72.91%
EBIT Margin 99.08%114.69%291.14%72.16%80.12%94.83%54.89%40.02%134.23%51.74%26.65%39.09%70.49%33.52%-85.31%70.03%46.24%28.24%102.82%-12.99%50.19%130.17%60.90%94.01%36.26%70.11%
EBITDA Margin 84.86%87.81%312.12%25.56%87.57%54.69%31.72%11.10%78.70%15.98%26.65%39.09%70.49%33.52%-85.31%70.03%46.24%28.24%102.82%-12.99%50.19%130.17%60.90%94.01%36.26%70.11%
Operating Margin 99.08%114.69%291.14%72.16%80.12%94.83%54.89%40.02%134.23%51.74%26.65%39.09%70.49%33.52%-85.31%70.03%46.24%28.24%102.82%-12.99%50.19%130.17%60.90%94.01%36.26%70.11%
Net Margin 91.08%94.78%316.19%21.78%117.82%115.95%64.08%27.74%145.37%37.86%9.32%22.79%91.72%38.44%-107.83%74.43%65.28%22.76%120.39%-0.75%36.18%142.80%56.32%76.28%15.66%72.91%
FCF Margin 85.35%2.55%74.23%2.68%-54.54%-41.86%4.02%63.26%-147.88%55.28%81.88%74.62%-135.58%56.51%63.18%101.70%22.82%-38.52%101.86%-13.11%-86.94%41.46%104.71%62.71%-42.55%
Efficiency
Assets Average 15.84B16.01B15.97B16.21B17.12B17.62B17.45B17.56B17.71B17.24B16.94B17.10B16.49B16.12B16.26B16.89B17.85B18.13B17.92B17.97B18.84B
Equity Average 6.65B8.28B9.60B9.85B9.87B10.12B10.40B10.32B10.20B10.28B10.41B9.97B9.67B9.82B9.70B9.83B9.97B9.81B10.01B10.30B10.07B9.65B9.56B
Invested Capital 12.38B7.16B15.31B15.61B15.71B15.66B16.23B17.48B17.34B17.24B17.51B17.53B16.64B16.94B16.94B15.72B16.22B16.00B17.35B17.87B17.95B17.41B17.51B18.57B
Asset Utilization Ratio 0.130.130.140.140.130.130.130.130.130.130.140.140.140.150.140.130.130.120.130.130.12
Leverage & Solvency
Interest Coverage Ratio 6.417.7421.036.7511.9716.248.306.1319.906.843.274.678.044.09-10.2810.205.303.2912.97-1.675.5011.055.508.193.065.37
Debt to Equity 1.020.630.610.600.600.570.690.700.710.690.680.750.730.730.640.610.620.780.740.740.780.840.93
Debt Ratio 0.500.380.370.370.370.360.410.410.420.410.400.420.420.420.390.370.380.430.420.420.430.440.46
Equity Ratio 0.490.600.610.620.620.630.590.590.580.590.590.570.580.570.600.620.610.550.570.570.560.520.50
Times Interest Earned 6.417.7421.036.7511.9716.248.306.1319.906.843.274.678.044.09-10.2810.205.303.2912.97-1.675.5011.055.508.193.065.37
Dividends & Payouts
FCF Payout Ratio 0.103.180.439.01-0.401.205.460.32-0.14-0.720.080.09-0.050.100.080.060.25-0.110.06-0.44-0.060.130.090.11-0.13
Valuation
Enterprise Value 0.07B0.09B30.08B29.29B34.38B30.66B28.35B24.67B27.06B26.16B27.43B27.26B26.18B23.77B19.74B18.84B21.00B19.20B17.23B19.18B17.44B19.95B22.77B22.83B
Market Capitalization 27.31B25.54B30.39B26.48B24.89B21.94B24.20B23.66B25.53B24.40B24.00B21.88B18.39B16.33B17.94B16.71B15.75B16.79B15.03B17.94B20.26B20.57B
Return Ratios
Return on Sales 1.29%1.34%1.39%0.80%0.80%0.87%0.68%0.54%0.53%0.40%0.40%0.10%0.26%0.20%0.16%0.72%0.53%0.46%0.76%0.59%0.78%0.72%0.55%
Return on Capital Employed 0.17%0.10%0.09%0.11%0.09%0.08%0.08%0.06%0.06%0.02%0.04%0.03%0.02%0.09%0.06%0.06%0.09%0.08%0.11%0.11%0.08%
Return on Assets 0.18%0.11%0.11%0.12%0.09%0.07%0.07%0.05%0.05%0.01%0.04%0.03%0.02%0.11%0.07%0.06%0.10%0.07%0.10%0.09%0.07%
Return on Equity 0.36%0.31%0.29%0.17%0.18%0.19%0.15%0.12%0.12%0.09%0.09%0.02%0.06%0.05%0.04%0.17%0.12%0.10%0.17%0.13%0.18%0.17%0.14%